These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 18506183
1. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI. Gambarota G, Leenders W, Maass C, Wesseling P, van der Kogel B, van Tellingen O, Heerschap A. Br J Cancer; 2008 Jun 03; 98(11):1784-9. PubMed ID: 18506183 [Abstract] [Full Text] [Related]
2. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, Heerschap A, Leenders W. Int J Cancer; 2008 May 01; 122(9):1981-6. PubMed ID: 18081012 [Abstract] [Full Text] [Related]
5. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG. Radiology; 2003 Nov 01; 229(2):429-38. PubMed ID: 14595147 [Abstract] [Full Text] [Related]
7. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats. Yang YM, Feng X, Yin le K, Li CC, Jia J, Du ZG. Acta Radiol; 2014 Sep 01; 55(7):864-73. PubMed ID: 24065200 [Abstract] [Full Text] [Related]
9. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. Beaumont M, Lemasson B, Farion R, Segebarth C, Rémy C, Barbier EL. J Cereb Blood Flow Metab; 2009 Oct 01; 29(10):1714-26. PubMed ID: 19584891 [Abstract] [Full Text] [Related]
11. Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches. Pannetier N, Lemasson B, Christen T, Tachrount M, Troprès I, Farion R, Segebarth C, Rémy C, Barbier EL. NMR Biomed; 2012 Feb 01; 25(2):218-26. PubMed ID: 21751270 [Abstract] [Full Text] [Related]
12. Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging. Wei L, Zhou G, Li Z, He L, Gao M, Tan J, Lei H. Magn Reson Imaging; 2007 Dec 01; 25(10):1442-8. PubMed ID: 17614231 [Abstract] [Full Text] [Related]
13. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Floris S, Blezer EL, Schreibelt G, Döpp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE. Brain; 2004 Mar 01; 127(Pt 3):616-27. PubMed ID: 14691063 [Abstract] [Full Text] [Related]
14. Histologic Distribution and Characteristics on MR Imaging of Ultrasmall Superparamagnetic Iron Oxide in Ethyl-nitrosourea-induced Endogenous Rat Glioma. Yamamoto A, Takaki K, Morikawa S, Murata K, Ito R. Magn Reson Med Sci; 2021 Sep 01; 20(3):264-271. PubMed ID: 32830172 [Abstract] [Full Text] [Related]
15. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. Turetschek K, Roberts TP, Floyd E, Preda A, Novikov V, Shames DM, Carter WO, Brasch RC. J Magn Reson Imaging; 2001 Jun 01; 13(6):882-8. PubMed ID: 11382948 [Abstract] [Full Text] [Related]
19. Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation? Kremer S, Pinel S, Védrine PO, Bressenot A, Robert P, Bracard S, Plénat F. J Neurooncol; 2007 Jun 01; 83(2):111-9. PubMed ID: 17443290 [Abstract] [Full Text] [Related]
20. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Turetschek K, Huber S, Floyd E, Helbich T, Roberts TP, Shames DM, Tarlo KS, Wendland MF, Brasch RC. Radiology; 2001 Feb 01; 218(2):562-9. PubMed ID: 11161179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]